An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity.
Yu D, Wagner S, Schütz M, Jeon Y, Seo M, Kim J, Brückner N, Kicuntod J, Tillmanns J, Wangen C, Hahn F, Kaufer BB, Neipel F, Eickhoff J, Klebl B, Nam K, Marschall M.
Yu D, et al. Among authors: marschall m.
Pharmaceutics. 2024 Jan 23;16(2):158. doi: 10.3390/pharmaceutics16020158.
Pharmaceutics. 2024.
PMID: 38399219
Free PMC article.